GSK Offers Price Freeze On Ventolin HFA In Bid For Early Phase-Out Of CFCs

GlaxoSmithKline has offered to freeze the wholesale price of its Ventolin HFA inhaler as part of its case for FDA to phase out chlorofluorocarbon albuterol metered-dose inhalers by December 31, 2005